Skip to main content
All lobbying firms

RK STRATEGIES, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$650,000 Income reported
11 Clients represented
63 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401107835), not by name.

 Clients 11
 Reported by year 2 years
  • 2026 $280,000 28 filings
  • 2025 $370,000 35 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 9
  • HOUSE OF REPRESENTATIVES 59
  • SENATE 59
  • Health & Human Services, Dept of (HHS) 23
  • Defense, Dept of (DOD) 17
  • Veterans Affairs, Dept of (VA) 14
  • Food & Drug Administration (FDA) 13
  • Defense Threat Reduction Agency (DTRA) 7
  • Justice, Dept of (DOJ) 2
  • Office of Management & Budget (OMB) 2
 Recent filings 63 total
Q3 report
NEUROTHERA LABS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 report
BULLBAG CORPORATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · posted Oct 20, 2026
View →
Q3 report
CLEARMIND MEDICINE, INC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
BREAKING BARRIERS TO SUBSTANCE USE RECOVERY
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 report
ELSE NUTRITION GH LTD.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 report
THE RECOVERY PLATFORM
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · posted Oct 20, 2026
View →
Q3 report
RECCE PHARMACEUTICALS LTD
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
NEXALIN TECHNOLOGY INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Registration
NEUROTHERA LABS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 2, 2026
View →
Q2 termination
IPILL, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q2 report
BULLBAG CORPORATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · posted Jul 18, 2026
View →
Q2 report
CLEARMIND MEDICINE, INC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q2 termination
ADIAL PHARMACEUTICALS, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 18, 2026
View →
Q2 report
BREAKING BARRIERS TO SUBSTANCE USE RECOVERY
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 18, 2026
View →
Q2 report
ELSE NUTRITION GH LTD.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 18, 2026
View →
Q2 report
THE RECOVERY PLATFORM
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · posted Jul 18, 2026
View →
Q2 report
RECCE PHARMACEUTICALS LTD
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q2 report
NEXALIN TECHNOLOGY INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q1 report
IPILL, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted Apr 20, 2026
View →
Registration
IPILL, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 20, 2026
View →

Showing the 20 most recent of 63 filings. Search the explorer for "RK STRATEGIES, INC.".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem